deoxygenated CH2Cl2. The mixture, which changes the colour
from red to orange, was stirred for 1 h. The solvent was
evaporated. Addition of ether followed by filtration through
canula, then evaporation, and finally addition of hexanes afforded
the complexes as orange solids.
112.1, 112.0, 89.0, 88.9, 84.7, 84.6, 83.5, 83.4, 83.1, 81.2, 79.3,
75.8, 74.9, 73.5, 68.5, 57.9, 32.8, 31.1, 30.9, 29.2, 28.0. 31P-NMR
(121.4 MHz): d (ppm) 123.5 (d, JPRh = 94.9 Hz). HRMS Calc. for
[C51H59O5PRhS]+: 917.2876. Found: 917.2188.
General procedure for the synthesis of the cationic complexes
L-Rh(NBD)OTf, 9–11
Complex [1-Rh(COD)]SbF6, 4
Starting from ligand
[Rh(COD)2]SbF6 (34.8 mg, 1 equiv.) and following the general
1
(32.5 mg, 0.06 mmoles) and
To a solution of [Rh(NBD)Cl]2 (0.7 equiv.) in dry deoxygenated
methylene chloride (1 mL) under argon at 0 ◦C was added a
solution of the ligand (1 equiv.) in dry methylene chloride at
procedure afforde◦d complex 4 (80%) as an orange solid. M.p.:
decomposes (190 C). [a]D20: -2.7 (c 0.2, CHCl3). H-NMR (500
1
0
◦C. The reaction was stirred at 0 ◦C for 5 min. After that
MHz, CDCl3): d (ppm) 7.96–7.92 (m, 2H), 7.60–7.29 (m, 8H),
5.78 (bs, 1H), 5.71 (bs, 1H), 4.80 (t, 1H, J = 5.6 Hz), 4.71 (d, 1H,
J = 10.2 Hz), 4.48–4.21 (m, 5H), 4.07 (brs, 1H), 3.88 (bs, 1H),
2.69–2.11 (m, 8 H), 2.04 (s, 3H), 1.63 (s, 3H), 1.43 (s, 3H), 1.21 (s,
the mixture was added via canula over a suspension of silver
trifluoromethanesulfonate (1.2 equiv.) and stirred 5 min at room
temperature. The reaction was filtered by canula and evaporated
until 0.3 mL of solvent, and finally addition of hexanes (5 mL)
afforded the complexes as orange solids.
9H). 13C-NMR (125 MHz, CDCl3): d (ppm) 170.6, 133.7 (d, JPC
=
50.8 Hz), 132.9, 132.7 (d, JPC = 59.6 Hz), 131.9 (d, JPC = 14.3 Hz),
131.7, 130.1 (d, JPC = 11.0 Hz), 129.7 (d, JPC = 11.7 Hz), 128.8
Complex [1-Rh(NBD)]TfO, 9
(d, JPC = 10.6 Hz), 114.9, 114.8, 110.9, 110.6, 110.5, 88.5 (d, JPC
=
Starting from ligand 1 (40 mg, 0.07 mmol), [Rh(NBD)Cl]2 (21.3
mg, 0.05 mmol) and AgOTf (24 mg, 0.09 mmol) and following
the general procedure afforded 45 mg (80% yield) of complex 9
as an orange solid. M.p.: decomposes (207 ◦C). [a]D: + 9.0 [c 0.2,
CHCl3]; 1H NMR (500 MHz, CDCl3): d (ppm) 7.92–7.88 (m, 2H),
7.60–7.58 (m, 3H), 7.48–7.45 (m, 5H), 5.04 (d, 1H, JHH = 10 Hz),
4.76 (t, 1H, J = 6 Hz), 4.49 (m, 1H), 4.40–4.35 (m, 2H), 4.25 (dd,
1H, J = 3 Hz and 12 Hz), 4.18–4.05 (m, 3H, H-2, 2H), 2.04 (s,
3H), 1.72 (bs, 2H), 1.52 (brs, 2H), 1.48 (s, 3H), 1.43 (s, 9H), 1.39 (s,
3H). 13C NMR (125 MHz, CDCl3): d (ppm) 170.6, 132.6, 132.1,
131.9, 131.8, 130.5, 130.4, 129.4, 129.3, 129.1, 128.9, 110.7, 81.1,
79.4, 78.3, 74.4, 74.0, 68.7, 63.4, 58.3, 53.2, 31.5, 29.0, 27.8, 26.1,
12.2 Hz), 83.8, 82.6 (d, JPC = 10.8 Hz), 80.2, 78.2 (d, JPC = 7.2 Hz),
74.7, 73.8, 63.3, 57.9, 32.1, 31.8, 31.6, 30.9, 29.7, 28.9, 28.1, 26.1,
20.7. 31P-NMR (121.4 MHz, CDCl3): d (ppm) 125.7 (d, JPRh = 94.9
Hz). Elemental Anal. Calc. for C35H47F6O6PRhSSb: C 43.54%, H
4.91%. Found: C 43.61%, H 5.08%.
Complex [2-Rh(COD)]SbF6, 5
Starting from ligand 2 (73 mg, 0.12 mmol) and [Rh(COD)2]SbF6
(67 mg, 0.12 mmol) and following the general procedure afforded
complex 5 as an orange solid in quantitative yield. M.p.: decom-
poses (129 ◦C). [a]D: -11.3 (c. 0.7, CHCl3). 1H NMR (400 MHz,
CDCl3): d (ppm) 7.95–7.91 (m, 2H), 7.60–7.52 (m, 3H), 7.40–7.36
(m, 5H), 5.73 (bs, 1H), 5.62(bs, 1H), 4.78 (t, 1H, = 5.7 Hz), 4.72 (d,
1H, J = 10.2 Hz), 4.40–4.32 (m, 4H), 4.22 (dd, 1H, J = 10.3 and
2.2 Hz), 4.08 (bs, 1H), 1.75 (d, 3H, J = 11.9 Hz), 1.63 (s, 3H), 1.51
(brs, 6H), 1.44 (d, 3H, J = 11.7 Hz), 1.42 (s, 3H). 13C NMR (400
MHz, CDCl3): d (ppm) 170.6, 133.9, 133.7, 133.4, 133.1, 132.7,
132.0, 131.9, 131.6, 129.9, 129.8, 129.6, 129.5, 128.8, 128.7, 115.2
(dd, JPC = 10.0 and 6.0 Hz), 110.4 (dd, JPC = 10.0 and 5.0 Hz), 88.7
(d, JPC = 12.5 Hz), 84.1, 82.4 (d, JPC = 11.0 Hz), 78.1 (d, JPC = 7.0
Hz), 77.8, 74.5, 73.8, 63.3, 61.1, 43.3, 35.1, 32.2, 31.6, 30.6, 29.0,
28.8, 28.2, 26.2, 20.8. 31P NMR (97.1 MHz, CDCl3): d (ppm) 125.6
(d, JPRh = 94.2 Hz). HRMS Calc. for [C41H53O6PRhS]+: 807.2356.
Found: 807.2335.
20.7. 31P NMR (121.4 MHz, CDCl3): d (ppm) 132.2 (d, JPRh
=
105.9 Hz). HRMS Calc. for [C34H43O6PRhS]+: 713.1573. Found:
713.1602.
Complex [2-Rh(NBD)]TfO, 10
Starting from ligand 2 (87 mg, 0.140 mmol), [Rh(NBD)Cl]2 (49.6
mg, 0.1 mmol) and AgOTf (39 mg, 0.154 mmol) and following
the general procedure afforded complex 10 (120 mg, 0.13 mmol,
88% yield) as an orange solid. [a]D: + 25.3 [c. 1, CHCl3]. M.p.:
decomposes (116 ◦C). 1H NMR (500 MHz, CDCl3): d (ppm) 7.93–
7.89 (m, 2H, Ph2P), 7.58–7.56 (m, 3H), 7.44–7.39 (m, 5H), 6.05–
5.85 (brs, 1H), 5.85–5.70 (bs, 1H), 5.00 (d, 1H, JHH = 10.0 Hz), 4.72
(t, 1H, J = 5.4 Hz), 4.45 (d, 1H, J = 6.6 Hz), 4.40–4.30 (m, 2H),
4.30–3.90 (m, 6H), 2.02–1.95 (m, 6H), 1.90–1.56 (m, 14H), 1.48 (s,
3H), 1.35 (s, 3H). 13C NMR (125 MHz, CDCl3): d (ppm) 170.5,
132.6, 133.7, 132.1, 132.0, 131.6, 130.2, 130.1, 129.4, 129.3, 129.0,
128.9, 110.7, 81.4, 78.3, 77.3, 74.3, 73.9, 63.3, 61.7, 53.3, 43.9, 35.2,
30.5, 27.8, 25.9, 20.7. 31P NMR (121.4 MHz, CDCl3): d (ppm)
130.06 (d, JPRh = 104.5 Hz). HRMS Calc. for [C40H49O6PRhS]+:
791.2043. Found: 791.2121.
Complex [3-Rh(COD)]SbF6, 6
Starting from ligand 3 (65 mg, 0.09 mmol) and [Rh(COD)2]SbF6
(70 mg, 0.09 mmol) and following the general procedure afforded
complex 6 as an orange solid in quantitative yield. M.p.: decom-
poses. [a]2D0: -3.8 (c 1.0, CHCl3). 1H-NMR (500 MHz, CDCl3): d
(ppm) 7.90 (m, 2H), 7.60 (m, 3H), 7.30–6.95 (m, 20H), 5.80 (bs,
2H), 4.91 (d, 1H, J = 7.1 Hz), 4.89 (d, 1H, J = 7.5 Hz), 4.75 (d,
1H, J = 7.5 Hz), 4.73 (d, 1H, J = 7.8 Hz), 4.65–4.53 (m, 4H), 4.12
(t, 1H, J = 8.6 Hz), 4.00 (bs, 1H), 3.89 (t, 1H, J = 8.5 Hz), 3.79
(brs, 1H), 3.72 (m, 2H), 3.68–3.62 (m, 1H), 2.85–2.00 (m, 8H),
1.20 (s, 9H). 13C-NMR (125 MHz, CDCl3): d (ppm) 137.7, 137.6,
137.5, 133.1, 132.2, 132.1,131.5, 130.2, 130.1, 129.7, 129.6, 128.6,
128.5, 128.5, 128.4, 128.3, 127.9, 127.8, 127.7, 127.6, 115.0, 114.9,
Complex [3-Rh(NBD)]TfO, 11
Starting from ligand 3 (98.5 mg, 0.16 mmol), [Rh(NBD)Cl]2 (36
mg, 0.08 mmol) and AgOTf (40.3 mg, 0.16 mmol) and following
the general procedure afforded complex 11 as a yellow solid (144
◦
mg, 92% yield). M.p.: decomposes (183 C). [a]2D0: +15.8 (c. 0.1,
This journal is
The Royal Society of Chemistry 2012
Org. Biomol. Chem., 2012, 10, 355–360 | 359
©